Dr. Tao Lowe is currently an Associate Professor of Pharmaceutical Sciences and Biomedical Engineering at University of Tennessee Health Science Center. Previously, she was an Associate Professor of Pharmaceutical Sciences at Thomas Jefferson University, and an Assistant Professor of Surgery, Bioengineering, and Materials Science and Engineering, and Co-Director of the Integrated Graduate Degree Molecular Toxicology Program at Pennsylvania State University. She received her Ph.D. with an Eximia Cum Laude from the University of Helsinki, Finland. She conducted two years’ postdoctoral research in the Department of Chemical Engineering at University of Wisconsin, Madison. Dr. Lowe’s research activities include design and development of multi-functional biomaterials for targeted and sustained drug and gene delivery, regenerative medicine, and biosensoring for the diagnoses and treatments of brain and eye diseases, cancers, bone fractures, and cartilage damages, and as well as contraception. She has published many high impact peer-reviewed papers, has been awarded US patents, and has lectured extensively throughout the global scientific community. She has received funding support from NIH, DOD, Coulter Foundation, JDRF, and FHI360/Bill & Melinda Gates Foundation, etc. Dr. Lowe has trained 60 students including PhD, MD, MD/PhD, PharmD, and PharmD/PhD. Her research activities have been recognized in the Royal Society of Chemistry's magazine, Chemistry in Britain, the Research Penn State Magazine, and via the press release of ARVO. Dr. Lowe is a peer reviewer for over 40 refereed journals, and editorial board member for 12 international journals. She is a frequent grant reviewer for NIH, NSF, DOD, EPA, USED, NSERC, ETHZ, etc. She has serviced on the committees of AAPS, ARVO, AIChE, CRS, BMES, SFB, etc. She was the 2010 Chair of the AIChE Biomaterials Area and is currently the Chair of the AAPS Nanotechnology Focus Group. Dr. Lowe has achieved numerous honors and awards including Early Career Award in Translational Research from the Coulter Foundation.

Biomaterials for Translational Research, Nanobiotechnology, Regenerative Medicine, Biosensors, Neural Engineering, Tissue Engineering, Biodegradable and Bioresponsive Polymers, Polysaccharides, Cyclodextrins, Hydrogels, Nanogels, Dendrimers etc..